Headline News about Immunovant Inc
![](/next-assets/images/schema-image-default.png)
Recap: Immunovant Q4 Earnings
May 22, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Immunovant's Future
April 25, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
7 Analysts Have This to Say About Immunovant
March 30, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/20/imvt.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2839.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Immunovant's Future
February 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7178.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29288.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/15/imvt_logo_light__bd91b615149c51a39665ed629443a4ea.png?width=1200&height=800&fit=crop)
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4375.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
February 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image19.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7171.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2546.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/703898/scientists-in-a-lab-smiling.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/05/image12.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/06/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/05/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image38.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18416.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image12.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image31.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/30/image24.jpeg?width=1200&height=800&fit=crop)
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18135.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/29/aapharma_14.png?width=1200&height=800&fit=crop)
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18112.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.